##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 63 Download : 57

##plugins.themes.academic_pro.article.main##

Abstract

Matrix metalloproteinase 9 is a proteolytic enzyme which is recently one of the more often studied biomarkers. Its possible use as a biomarker of neuronal damage in stroke, heart diseases, tumors, multiple sclerosis, and epilepsy is being widely indicated. In epilepsy, MMP-9 is suggested to play a role in epileptic focus formation and in the stimulation ofseizures. The increase of MMP- 9 activity in the epileptic focus was observed both in animal models and in clinical studies. MMP-9 contributes to formation of epileptic focus,for example, by remodeling ofsynapses. Its proteolytic action on the elements of blood-brain barrier and activation of chemotactic processes facilitates accumulation of inflammatory cells and induces seizures. Also, modification of glutamatergic transmission by MMP-9 is associated with seizures.

Keywords

Matrix metalloproteinase-9 neuroinflammation epilepsy

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Sultonova Dilbar Azamat qizi., & Azizova R.B. (2023). Matrix metalloproteinase 9: A Representative Diagnostic Biomarker for Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis. Texas Journal of Medical Science, 27, 104–110. https://doi.org/10.62480/tjms.2023.vol27.pp104-110
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. P. E. Van Den Steen, B. Dubois, I. Nelissen, P. M. Rudd, R.A. Dwek, and G. Opdenakker, “Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP- 9),” Critical Reviews in Biochemistry and Molecular Biology, vol. 37, no. 6, pp. 375–536, 2002
  2. ] H. Mizoguchi, J. Nakade, M. Tachibana et al., “Matrix metal- loproteinase-9 contributes to kindled seizure development in pentylenetetrazole-treated mice by converting pro-BDNF to mature BDNF in the hippocampus,” Journal of Neuroscience, vol. 31, no. 36, pp. 12963–12971, 2011.
  3. J. Dzwonek, M. Rylski, and L. Kaczmarek, “Matrix metallopro- teinases and their endogenous inhibitors in neuronal physiol- ogy of the adult brain,” FEBS Letters, vol. 567, no. 1, pp. 129–135, 2004.
  4. A. K. Sharma, R. Y. Reams, W. H. Jordan, M. A. Miller, H.L. Thacker, and P. W. Snyder, “Mesial temporal lobe epilepsy: pathogenesis, induced rodent models and lesions,” Toxicologic Pathology, vol. 35, no. 7, pp. 984–999, 2007.
  5. Azizova, R. B. (2023). POTENTIAL BIOMARKER FOR EPILEPSY: HIGH-MOBILITY GROUP BOX 1 PROTEIN (HMGB1). Horizon: Journal of Humanity and Artificial Intelligence, 2(6), 47-52.
  6. Sultonova, D. A., Azizova, R. B., Parpibayeva, D. A., & Musayeva, M. A. (2023). HIPPOCAMPAL SCLEROSIS: PATHOGENISIS AND IMAGING.
  7. J. A. Gorter, E. A. van Vliet, and E. Aronica, “Status epilepticus, blood-brain barrier disruption, inflammation, and epileptoge- nesis,” Epilepsy and Behavior, vol. 49, pp. 13–16, 2015.
  8. A. Szklarczyk, J. Lapinska, M. Rylski, R. D. McKay, and L. Kacz- marek, “Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus,” The Journal of Neuroscience, vol. 22, no. 3, pp. 920–930, 2002.
  9. Азизова, Р. Б. (2022). Когнитивные расстройства при различных форм эпилепсии.
  10. Z.-L. Chen and S. Strickland, “Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin,” Cell, vol. 91, no. 7, pp. 917–925, 1997.
  11. P. E. Gottschall, X. Yu, and B. Bing, “Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture,” Journal of Neuroscience Research, vol. 42, no. 3, pp. 335–342, 1995.
  12. P. Van Lint and C. Libert, “Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation,” Journal of Leukocyte Biology, vol. 82, no. 6, pp. 1375–1381, 2007.
  13. M. De Bock, N. Wang, E. Decrock, G. Bultynck, and L. Leybaert, “Intracellular cleavage of the Cx43 C-terminal domain by matrix-metalloproteases: a novel contributor to inflammation?” Mediators of Inflammation, vol. 2015, Article ID 257471, 18 pages, 2015.
  14. E. A. Van Vliet, S. D. C. Arau´jo, S. Redeker, R. Van Schaik, E. Aronica, and J. A. Gorter, “Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy,” Brain, vol. 130, no. 2, pp. 521–534, 2007.
  15. A. Crespel, P. Coubes, M.-C. Rousset et al., “Inflammatory reactions in human medial temporal lobe epilepsy with hip- pocampal sclerosis,” Brain Research, vol. 952, no. 2, pp. 159–169, 2002.

Most read articles by the same author(s)